Perspective Therapeutics (CATX) Tax Provisions (2023)
Perspective Therapeutics (CATX) reported Tax Provisions of $10.5 million for Q4 2023, up 199.9% sequentially from -$10.5 million in Q1 2023.
Perspective Therapeutics (CATX) Tax Provisions (2023) Analysis & Trends
Perspective Therapeutics (CATX) has 1 years of Tax Provisions data on file, last reported at $10.5 million in Q4 2023.
- For the quarter ending Q4 2023, Tax Provisions changed N/A year-over-year to $10.5 million; the trailing twelve-month figure through Dec 2023 stood at -$10000.0 (changed N/A YoY), and the FY2023 full-year result was -$10000.0, changed N/A from the prior year.
- Tax Provisions improved to $10.5 million in Q4 2023, from -$10.5 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $10.5 million in Q4 2023 to a low of -$10.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 70.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 10.49 Mn |
| Mar 31, 2023 | -10.50 Mn |